MedPath

Collaborative study for HyperglycemIc patients by Pitavastatin INterventio

Not Applicable
Conditions
Hypercholesterolemiac patients with diabetes mellitus
Registration Number
JPRN-UMIN000004834
Lead Sponsor
Chu-NET
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients under insulin treatment (2)Patients with history of cardiovascular events (ischemic heart disease, cerebral vascular disease, etc.) (3)CK (CPK) > upper limit of normal (ULN) (4)AST (GOT) and ALT (GPT) > 3 times ULN (5)Serum creatinine > 1.5 mg/dL for male, 1.3 mg/dL for female, eGFR < 50 ml/min/1.73 m2 (6)Patients judged to be inappropriate for this study by the investigators (7)Under 20 years old

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes of HbA1c from the baseline to 24 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath